Plasmodium berghei NK65 induces cerebral leukocyte recruitment in vivo: An intravital microscopic study

Acta Tropica

Volumn 120, Issue 1-2, 2011, Pages 31-39

  Lacerda Queiroz, Norinne ^a   Lima, Onésia Cristina Oliveira ^a   Carneiro, Cláudia Martins ^b   Vilela, Márcia Carvalho ^a   Teixeira, Antônio Lúcio ^a   Carvalho, Andrea Teixeira ^c   Araújo, Márcio Sobreira Silva ^c   Martins Filho, Olindo Assis ^c   Braga, Érika Martins ^a   Carvalho Tavares, Juliana ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Cerebral inflammation; Chemokines; Experimental malaria; Intravital microscopy; Microcirculation; Plasmodium berghei NK65

Indexed keywords

CD19 ANTIGEN; CD69 ANTIGEN; CXCL1 CHEMOKINE; CXCL9 CHEMOKINE; EVANS BLUE; GAMMA INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MIGRATION INHIBITION FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

BRAIN; EXPERIMENTAL STUDY; HISTOPATHOLOGY; INFECTIOUS DISEASE; MALARIA; MICROSCOPY; NERVOUS SYSTEM DISORDER; PARASITE; PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN EDEMA; BRAIN TISSUE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DEATH; CELL ISOLATION; CELL PROLIFERATION; CONTRAST MEDIUM EXTRAVASATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENCEPHALITIS; FEMALE; GLIA CELL; HISTOPATHOLOGY; IMMUNOPHENOTYPING; IN VIVO STUDY; LEUKOCYTE ADHERENCE; LEUKOCYTE ROLLING; LYMPHOCYTE SUBPOPULATION; MICROSCOPY; MICROVASCULATURE; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; SURVIVAL RATE; UPREGULATION; WEIGHT REDUCTION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CAPILLARY PERMEABILITY; CELL ADHESION; CHEMOKINES; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTES; MALARIA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; PLASMODIUM BERGHEI; SPECIES SPECIFICITY;

ANIMALIA; MUS; PLASMODIUM BERGHEI; RODENTIA;

EID: 80052078767     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2011.04.020     Document Type: Article

References (45)

1. Baatz H., Steinbauer M., Harris A.G., Krombach F. Kinetics of white blood cell staining by intravascular administration of rhodamine 6G. Int. J. Microcirc. Clin. Exp. 1995, 15:85-91.
2. Bagot S., Campino S., Penha-Gonçalves C., Pied S., Cazenave P.A., Holmberg D. Identification of two cerebral malaria resistance loci using an inbred wild-derived mouse strain. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:9919-9923.
3. Beale G.H., Carter R., Walliker D. Genetics. Rodent Malaria 1978, 213-245. Academic Press, London. R. Killick-Kendrick, W. Peters (Eds.).
4. Belayev L., Busto R., Zhao W., Ginsberg M.D. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res. 1996, 739:88-96.
5. Belnoue E., Kayibanda M., Vigario A.M., Deschemin J.C., van Rooijen N., Viguier M., Snounou G., Rénia L. On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J. Immunol. 2002, 169:6369-6375.
6. Belnoue E., Potter S.M., Rosa D.S., Mauduit M., Grüner A.C., Kayibanda M., Mitchell A.J., Hunt N.H., Rénia L. Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria. Parasite Immunol. 2008, 30:544-553.
7. Brenier-Pinchart M.P., Pelloux H., Derouich-Geurgour D., Ambroise-Thomas P. Chemokines in host protozoan parasite interactions. Trends Parasitol. 2001, 17:292-296.
8. Carvalho-Tavares J., Hickey M.J., Hutchison J., Michaud J., Sutcliffe I.T., Kubes P. A role for platelets and endothelial selectins in tumor necrosis factor-alpha-induced leukocyte recruitment in the brain microvasculature. Circ. Res. 2000, 87:1141-1148.
9. Chang W.L., Li J., Sun G., Chen H.L., Specian R.D., Berney S.M., Granger D.N., van der Heyde H.C. P-Selectin contributes to severe experimental malaria but is not required for leukocyte adhesion to brain microvasculature. Infect. Immun. 2003, 71:1911-1918.
10. Clark I.A., Ilschner S., MacMicking J.D., Cowden W.B. TNF and Plasmodium berghei ANKA-induced cerebral malaria. Immunol. Lett. 1990, 25:195-198.
11. de Souza J.B., Riley E.M. Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infect. 2002, 4:291-300.
12. dos Santos A.C., Roffê E., Arantes R.M., Juliano L., Pesquero J.L., Pesquero J.B., Bader M., Teixeira M.M., Carvalho-Tavares J. Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice. J. Neuroinflamm. 2008, 5:49.
13. Engwerda C.R., Mynott T.L., Sawhney S., De Souza J.B., Bickle Q.D., Kaye P.M. Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J. Exp. Med. 2002, 195:1371-1377.
14. Grau G.E., Piguet P.F., Engers H.D., Louis J.A., Vassali P., Lambert P.H. L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria. J. Immunol. 1986, 137:2348-2354.
15. Grau G.E., Fajardo L.F., Piguet P.F., Allet B., Lambert P.H., Vassalli P. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 1987, 237:1210-1212.
16. Grau G.E., Piguet P.F., Vassalli P., Lambert P.H. Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol. Rev. 1989, 112:49-70.
17. Grau G.E., Bieler G., Pointaire P., De Kossodo S., Tacchini-Cotier F., Vassalli P., Piguet P.F., Lambert P.H. Significance of cytokine production and adhesion molecules in malarial immunopathology. Immunol. Lett. 1990, 25:189-194.
18. Grech K., Watt K., Read A.F. Host-parasite interactions for virulence and resistance in a malaria model system. J. Evol. Biol. 2006, 19:1620-1630.
19. + T cells to the brain during Plasmodium berghei-mediated cerebral malaria. J. Immunol. 2007, 178:5779-5788.
20. Hanum P.S., Hayano M., Kojima S. Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain. Int. Immunol. 2003, 15:633-640.
21. Hearn J., Rayment N., Landon D.N., Katz D.R., De Souza J.B. Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature. Infect. Immun. 2000, 68:5364-5376.
22. Hunt N.H., Golenser J., Chan-Ling T., Parekh S., Rae C., Potter S., Medana I.M., Miu J., Ball H.J. Immunopathogenesis of cerebral malaria. Int. J. Parasitol. 2006, 36:569-582.
23. Karunaweera N.D., Grau G.E., Gamage P., Carter R., Mendis K.N. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:3200-3203.
24. Laranjeiras R.F., Brant L.C., Lima A.C., Coelho P.M., Braga E.M. Reduced protective effect of Plasmodium berghei immunization by concurrent Schistosoma mansoni infection. Mem. Inst. Oswaldo Cruz. 2008, 103:674-677.
25. Lou J., Gasche Y., Zheng L., Critico B., Monso-Hinard C., Juillard P., Morel P., Buurman W.A., Grau G.E. Differential reactivity of brain microvascular endothelial cells to TNF reflects the genetic susceptibility to cerebral malaria. Eur. J. Immunol. 1998, 28:3989-4000.
26. Miller L.H., Baruch D.I., Marsh K., Doumbo O.K. The pathogenic basis ofmalaria. Nature 2002, 415:673-679.
27. Ono S.J., Nakamura T., Miyazaki D., Ohbayashi M., Dawson M., Toda M. Chemokines: roles in leukocyte development, trafficking, and effector function. J. Allergy Clin. Immunol. 2003, 111:1185-1199.
28. Pease J.E., Williams T.J. The attraction of chemokines as a target for specific anti-inflammatory therapy. Br. J. Pharmacol. 2006, 147(SUPPL. 1):S212-221.
29. i-linked receptors. J. Immunol. 2002, 168:1940-1949.
30. Piguet P.F., Da Laperrousaz C., Vesin C., Tacchini-Cottier F., Senaldi G., Grau G.E. Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient mice. Infect. Immun. 2000, 68:3822-3829.
31. Ransohoff R.M. The chemokine system in neuroinflammation: an update. J. Infect. Dis. 2002, 186(SUPPL. 2):S152-S156.
32. Saunders N.R., Ek C.J., Habgood M.D., Dziegielewska K.M. Barriers in the brain: a renaissance?. Trends Neurosci. 2008, 31:279-286.
33. Scheiermann C., Colom B., Meda P., Patel N.S., Voisin M.B., Marrelli A., Woodfin A., Pitzalis C., Thiemermann C., Aurrand-Lions M., Imhof B.A., Nourshargh S. Junctional adhesion molecule-C mediates leukocyte infiltration in response to ischemia reperfusion injury. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1509-1515.
34. Shaffer N., Grau G.E., Hedberg K., Davachi F., Lyamba B., Hightower A.W., Breman J.G., Ngyen-Dinh P. Tumor necrosis factor and severe malaria. J. Infect. Dis. 1991, 163:96-101.
35. Snow R.W., Guerra C.A., Noor A.M., Myint H.Y., Hay S.I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005, 434:214-217.
36. Song L., Pachter J.S. Monocyte chemoattactant protein-1 alters expression of tight junction-associated proteins in brain microvascular endothelial cells. Microvasc. Res. 2004, 67:78-89.
37. Teixeira-Carvalho A., Martins-Filho O.A., Andrade Z.A., Cunha-Mello J.R., Wilson R.A., Corrêa-Oliveira R. The study of T-cell activation in peripheral blood and spleen of hepatosplenic patients suggests an exchange of cells between these two compartments in advanced human Schistosomiasis mansoni infection. Scand. J. Immunol. 2002, 56:315-322.
38. Togbe D., de Sousa P.L., Fauconnie M., Boissay V., Fick L., Scheu S., Pfeffer K., Menard R., Grau G.E., Doan B.T., Beloeil J.C., Renia L., Hansen A.M., Ball H.J., Hunt N.H., Ryffel B., Quesniaux V.F. Both functional LTbeta receptor and TNF receptor 2 are required for the development of experimental cerebral malaria. PLoS ONE 2008, 3:e2608.
39. Thumwood C.M., Hunt N.H., Clark I.A., Cowden W.B. Breakdown of the blood-brain barrier in murine cerebral malaria. Parasitology 1988, 96:579-589.
40. Van den Steen P.E., Deroost K., Aelst I.V., Geurts N., Martens E., Struyf S., Nie C.Q., Hansen D.S., Matthys P., Van Damme J., Opdenakker G. CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-gamma-induced chemokines. Eur. J. Immunol. 2008, 38:1082-1095.
41. Van den Steen P.E., Geurts N., Deroost K., Van Aelst I., Verhenne S., Heremans H., Van Damme J., Opdenakker G. Immunopathology and dexamethasone therapy in a new model for malaria-associated acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 2010, 181:957-968.
42. Van Hensbroek M.B., Palmer A., Onyiorah E., Schneider G., Jaffar S., Dolan G., Memming H., Frenkel J., Enwere G., Bennett S., Kwiatkowski D., Greenwood B. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J. Infect. Dis. 1996, 174:1091-1097.
43. Wassmer S.C., Combes V., Candal F.J., Juhan-Vague I., Grau G.E. Platelets potentiate brain endothelial alterations induced by Plasmodium falciparum. Infect. Immun. 2006, 74:645-653.
44. World Health Organisation Health Report 2000. Health Systems: Improving Performance 2000, WHO, Geneva.
45. Yoshimoto T., Takahama Y., Wang C.R., Yoneto T., Waki S., Nariuchi H. A pathogenic role of IL-12 in blood-stage murine malaria lethal strain Plasmodium berghei NK65 infection. J. Immunol. 1998, 160:5500-5505.